These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19245977)

  • 1. Binary sign in Anderson-Fabry cardiomyopathy.
    Pieroni M; Crea F
    J Am Coll Cardiol; 2009 Mar; 53(9):813-4; author reply 814-5. PubMed ID: 19245977
    [No Abstract]   [Full Text] [Related]  

  • 2. The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy.
    Kounas S; Demetrescu C; Pantazis AA; Keren A; Lee PJ; Hughes D; Mehta A; Elliott PM
    J Am Coll Cardiol; 2008 May; 51(21):2058-61. PubMed ID: 18498962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.
    Koskenvuo JW; Engblom E; Kantola IM; Hartiala JJ; Saraste A; Kiviniemi TO; Mononen I; Saraste M
    Clin Physiol Funct Imaging; 2009 May; 29(3):177-80. PubMed ID: 19320660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy.
    Mundigler G; Gaggl M; Heinze G; Graf S; Zehetgruber M; Lajic N; Voigtländer T; Mannhalter C; Sunder-Plassmann R; Paschke E; Fauler G; Sunder-Plassmann G
    Eur J Echocardiogr; 2011 Oct; 12(10):744-9. PubMed ID: 21857019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease.
    Cianciulli TF; Saccheri MC; Fernández SP; Fernández CC; Rozenfeld PA; Kisinovsky I
    Echocardiography; 2015 May; 32(5):860-3. PubMed ID: 25684266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic or pathologic hypertrophy: how can we know?
    Lai EJ; Rakowski H
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):919-22. PubMed ID: 24972675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomen est omen. Fabry disease.
    Weidemann F; Wanner C; Breunig F
    Eur J Echocardiogr; 2008 Nov; 9(6):831-2. PubMed ID: 18492655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case images: apical pouches with hypertrophic cardiomyopathy.
    Uçar FM; Ozeke O; Topaloğlu S; Gölbaşı Z
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):589. PubMed ID: 25362957
    [No Abstract]   [Full Text] [Related]  

  • 10. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2005 Nov; 21(11):795-6. PubMed ID: 16280960
    [No Abstract]   [Full Text] [Related]  

  • 11. A tale of two ventricles: unusual causes of left ventricular hypertrophy.
    Pearlamn AS
    Am Heart Hosp J; 2004; 2(4):235-8. PubMed ID: 15538061
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.
    Maron BJ; Ho CY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):65-8. PubMed ID: 19356535
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexpected severe LVH in the elderly: consider Fabry's disease.
    Sorrell VL; Ross WD; Gregoire J; Lai LW; Lien YH
    Echocardiography; 2008 Mar; 25(3):345-8. PubMed ID: 18177384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management].
    Pieruzzi F; Pieroni M; Zachara E; Marziliano N; Morrone A; Cecchi F
    G Ital Cardiol (Rome); 2015 Nov; 16(11):630-8. PubMed ID: 26571477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac manifestations in Fabry disease].
    Lappegård KT; Aass H
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tissue doppler imaging consistently defects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy].
    Cardim N
    Rev Port Cardiol; 2002 Feb; 21(2):233-5. PubMed ID: 11963292
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study.
    Paraskevaidis IA; Panou F; Papadopoulos C; Farmakis D; Parissis J; Ikonomidis I; Rigopoulos A; Iliodromitis EK; Th Kremastinos D
    Heart; 2009 Mar; 95(6):483-9. PubMed ID: 18765436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac manifestations of Anderson-Fabry disease and efficacy of enzyme replacement therapy].
    Hagège A
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S238-42. PubMed ID: 21211672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Anderson-Fabry disease: lessons from a 25-year-follow up.
    Brito D; Miltenberger-Miltenyi G; Moldovan O; Navarro C; Madeira HC
    Rev Port Cardiol; 2014 Apr; 33(4):247.e1-7. PubMed ID: 24830310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease.
    Nagueh SF
    Heart; 2003 Aug; 89(8):819-20. PubMed ID: 12860841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.